Maze Therapeutics (MAZE) Change in Cash (2024 - 2026)

Maze Therapeutics (MAZE) has 3 years of Change in Cash data on file, last reported at $9.5 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 90.24% year-over-year to $9.5 million; the trailing twelve-month figure through Mar 2026 stood at -$95.6 million (down 136.17% YoY), and the FY2025 full-year result was -$7.6 million, down 104.51% from the prior year.
• Change in Cash climbed to $9.5 million in Q1 2026, from -$127.5 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $145.0 million in Q2 2024 to a low of -$127.5 million in Q4 2025.
• A 3-year average of $18.8 million and a median of $9.5 million in 2026 frame the typical range for Change in Cash.
• Peak annual rise in Change in Cash reached 11178.96% in 2025, while the deepest fall reached 370.16% in 2025.
• Tracing MAZE's Change in Cash over 3 years: stood at $47.2 million in 2024, then sank by 370.16% to -$127.5 million in 2025, then jumped by 107.46% to $9.5 million in 2026.
• Business Quant data shows MAZE's Change in Cash at $9.5 million in Q1 2026, -$127.5 million in Q4 2025, and $52.2 million in Q3 2025.